Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SAVA | Cassava Sciences, Inc. | -4.52% | 48.58 | 0.0% | $711.87m | |
| GWPH | GW Pharmaceuticals Plc | -0.28% | 214.25 | 6.1% | $393.29m | |
| HZNP | Horizon Therapeutics Plc | 0.38% | 90.91 | 5.5% | $197.75m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.58% | 168.04 | 2.3% | $189.90m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 0.58% | 31.46 | 14.1% | $185.11m | |
| BHC | Bausch Health Cos., Inc. | 0.58% | 31.46 | 0.0% | $141.41m | |
| CTLT | Catalent, Inc. | 1.07% | 113.45 | 2.1% | $115.20m | |
| ICLR | ICON plc | -2.04% | 180.68 | 4.2% | $96.12m | |
| ARGX | argenx SE | -2.59% | 330.68 | 0.0% | $81.80m | |
| PRGO | Perrigo Co. Plc | -1.64% | 40.11 | 6.8% | $71.31m | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | -2.46% | 1.19 | 0.2% | $66.62m | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | 0.79% | 4.50 | 6.0% | $58.84m | |
| AMRN | Amarin Corp. Plc | -3.02% | 6.74 | 1.5% | $49.30m | |
| UTHR | United Therapeutics Corp. | -0.96% | 167.18 | 14.1% | $44.01m | |
| PBH | Prestige Consumer Healthcare, Inc. | 0.12% | 41.82 | 4.0% | $40.75m |
Company Profile
CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.